CN103070998A - Externally-applied plaster for curing pain of rheumatic joints - Google Patents
Externally-applied plaster for curing pain of rheumatic joints Download PDFInfo
- Publication number
- CN103070998A CN103070998A CN2013100061636A CN201310006163A CN103070998A CN 103070998 A CN103070998 A CN 103070998A CN 2013100061636 A CN2013100061636 A CN 2013100061636A CN 201310006163 A CN201310006163 A CN 201310006163A CN 103070998 A CN103070998 A CN 103070998A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- plaster
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011505 plaster Substances 0.000 title claims abstract description 12
- 208000002193 Pain Diseases 0.000 title claims abstract description 10
- 206010072736 Rheumatic disease Diseases 0.000 title abstract description 7
- 230000000552 rheumatic Effects 0.000 title abstract 3
- 210000001503 Joints Anatomy 0.000 title abstract 2
- 239000003814 drug Substances 0.000 claims abstract description 21
- 241000903946 Clematidis Species 0.000 claims abstract description 9
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960000846 Camphor Drugs 0.000 claims abstract description 7
- 229940079593 drugs Drugs 0.000 claims abstract description 7
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 4
- 229930007890 camphor Natural products 0.000 claims abstract description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 241001163443 Daphne giraldii Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 235000012907 honey Nutrition 0.000 claims description 8
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 286.4,136.0 L 268.2,147.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 268.2,147.9 L 248.8,138.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-2 atom-3' d='M 248.8,138.1 L 230.6,150.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 230.6,150.0 L 211.2,140.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-4 atom-5' d='M 211.2,140.2 L 193.1,152.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-5 atom-6' d='M 193.1,152.0 L 173.7,142.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 173.7,142.2 L 155.5,154.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 155.5,154.1 L 136.1,144.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 136.1,144.3 L 117.9,156.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 117.9,156.1 L 98.6,146.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 98.6,146.3 L 80.4,158.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 80.4,158.2 L 74.2,155.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-11 atom-12' d='M 74.2,155.1 L 68.0,152.0' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 61.1,140.9 L 61.3,133.8' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 61.3,133.8 L 61.4,126.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-18 atom-12' d='M 43.7,161.6 L 49.1,157.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-18 atom-12' d='M 49.1,157.5 L 54.4,153.4' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 61.4,126.7 L 44.7,112.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-14 atom-15' d='M 44.7,112.8 L 23.5,117.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 23.5,117.2 L 13.6,136.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 13.6,136.6 L 22.7,156.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-17 atom-18' d='M 22.7,156.3 L 43.7,161.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 41.6,162.0 L 43.0,169.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 43.0,169.0 L 44.5,175.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 45.9,161.2 L 47.3,168.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 47.3,168.1 L 48.7,175.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='58.4' y='152.7' class='atom-12' style='font-size:8px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#4284F4' >N</text>
<text x='45.5' y='187.2' class='atom-19' style='font-size:8px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,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 CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 6
- 229960003639 Laurocapram Drugs 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nMzAwcHgnIGhlaWdodD0nMzAwcHgnIHZpZXdCb3g9JzAgMCAzMDAgMzAwJz4KPCEtLSBFTkQgT0YgSEVBREVSIC0tPgo8cmVjdCBzdHlsZT0nb3BhY2l0eToxLjA7ZmlsbDojRkZGRkZGO3N0cm9rZTpub25lJyB3aWR0aD0nMzAwLjAnIGhlaWdodD0nMzAwLjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8dGV4dCB4PScxMDAuNScgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5IPC90ZXh0Pgo8dGV4dCB4PScxMjYuMScgeT0nMTg2LjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MjZweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID4yPC90ZXh0Pgo8dGV4dCB4PScxMzguMCcgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5PPC90ZXh0Pgo8L3N2Zz4K data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000725145 Homalomena Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 208000006820 Arthralgia Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 241000758794 Asarum Species 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 abstract 1
- 240000005801 Carthamus tinctorius Species 0.000 abstract 1
- 241000934856 Daphne Species 0.000 abstract 1
- 241000123866 Homalomena occulta Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000004678 Panax pseudoginseng Species 0.000 abstract 1
- 241000331449 Vincetoxicum pycnostelma Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000002365 multiple layer Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001737 promoting Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 12
- 210000003205 Muscles Anatomy 0.000 description 3
- 229940025250 camphora Drugs 0.000 description 3
- 239000010238 camphora Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000002615 Epidermis Anatomy 0.000 description 2
- 206010022114 Injury Diseases 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 210000002784 Stomach Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic Effects 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 210000003414 Extremities Anatomy 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 206010024770 Local swelling Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010039073 Rheumatoid arthritis Diseases 0.000 description 1
- 208000008552 Soft Tissue Injury Diseases 0.000 description 1
- 210000004304 Subcutaneous Tissue Anatomy 0.000 description 1
- 210000001835 Viscera Anatomy 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 201000005569 gout Diseases 0.000 description 1
- 230000001861 immunosuppresant Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 230000001537 neural Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 230000000149 penetrating Effects 0.000 description 1
- 230000000607 poisoning Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000003236 psychic Effects 0.000 description 1
- 230000001047 pyretic Effects 0.000 description 1
- 230000000306 recurrent Effects 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 200000000019 wound Diseases 0.000 description 1
Abstract
The invention provides an externally-applied plaster for curing pain of rheumatic joints. The externally-applied plaster is mainly composed of the following components: radix angelicae pubescentis, corydalis tuber, safflower carthamus, homalomena occulta, lycopodium clavatum, girald daphne bark, radix clematidis, beautiful sweetgum fruit, pseudo-ginseng, ligusticum wallichii, asarum, cynanchum paniculatum, radix angelicae, camphor, and the like. The externally-applied plaster has effects of dispelling wind and eliminating dampness, stretching channels and dredging collaterals, and promoting blood circulation to remove blood stasis. The drug is different from conventional treatment scheme only used for curing pain of rheumatic pain joints, adopts an external treatment strapping, has multiple layers and targets, achieves prevention and treatment, treats both symptoms and root causes, and has a unique treatment method and reliable curative effect.
Description
Technical field
The present invention relates to a kind of external patch unguentum for the treatment of the rheumatalgia arthralgia.
Background technology
The rheumatalgia arthralgia is rheumatism volume cardinal symptom, and rheumatism refers to take muscle, arthralgia as a main class disease.The connective tissue of major effect health may be that immune system injury causes.The traditional Chinese medical science thinks because wind, the exopathogen such as cold, wet, hot are attacked human body, and the impatency passages through which vital energy circulates causes.Motherland's medical science early has penetrating record to this disease.Alleged " severe and migratory arthralgia ", " gout " of ancient medicine, " numbness " etc. are all as this class disease, think many and invade in an opponent's defence human body by wind-cold damp pathogen gas, or have an intrinsic heat, the heat-transformation of a specified duration of wind and cold damp-stagnancy, the meridians of being detained, inaccessible obstructed forming, if with the passing of time do not heal, deficiency of both the liver and kidney, muscles and bones are lost in moistening foster, so that joint deformity is stiff.
In general, suffering from cold, humidity, fatigue, psychic trauma, malnutrition, wound etc., often is the risk factor of primary disease.Main clinical manifestation is joint, muscle, neural acid, swollen, painful, swollen, cold, numb, and chance cold rnning weight gets and hotly then delays.At present, doctor trained in Western medicine there is no specific medicament, and traditional Chinese medical science Chinese medicine for oral administration trouble is inconvenient, and has the intestines and stomach to stimulate.
Rheumatism is a kind of commonly encountered diseases, frequently-occurring disease.Along with the aging of population, the number of patients showed increased of such disease.In recent years, rheumatismal Progress in Medication major embodiment is following several respects:
(1) nonsteroidal antiinflammatory drug is constantly updated.(2) slow-acting drug: this type of medicine also claims to improve state of an illness medicine.(3) immunosuppressant.(4) glucocorticoid.(5) biological preparation.(6) transplantation therapy.(7) other rheumatism treatment medicines.But western medicine exists, and side effect is large, expense is high, treatment not thoroughly, the easy shortcoming such as recurrence.
Summary of the invention
The objective of the invention is for the deficiencies in the prior art, a kind of external plaster for the treatment of Fengshi Guanjie pain is provided, this curative effect of medicine is high, and expense is low, and is easy to use simple and direct, has no side effect, and rear being difficult for recurs.
The present invention treats the external plaster of Fengshi Guanjie pain, is comprised of by weight following bulk drugs:
90～120 parts of Radix Angelicae Pubescentiss, 80～100 parts of Rhizoma Corydalis, 80～100 parts of Herba Asaris, 30～50 parts on Flos Carthami, 40～60 parts of Rhizoma Homalomenaes, 30～50 parts of Herba Lycopodiis, 40～60 parts of Daphne giraldii Nitsche, 30～50 parts of Radix Clematidis, 40～60 parts of Fructus Liquidambaris, 30～60 parts of Radix Notoginseng, 30～50 parts of Rhizoma Chuanxiongs, 30～50 parts of Radix Cynanchi Paniculatis, 40～60 parts of the Radixs Angelicae Dahuricae, 20～40 parts of Camphoras, 10～20 parts of laurocaprams, 150～250 parts of refined honeys, 100～250 parts of lanolines, 70～150 parts of propylene glycol.
The preparation method of this plaster is: Radix Angelicae Pubescentis, Rhizoma Corydalis, Rhizoma Homalomenae, Daphne giraldii Nitsche, Radix Notoginseng, Rhizoma Chuanxiong, Herba Asari, the Radix Angelicae Dahuricae, camphor powder are broken into fine powder (crossing 100 mesh sieves), and mixing, for subsequent use; The decocting that Flos Carthami, Herba Lycopodii, Radix Clematidis, Fructus Liquidambaris, Radix Cynanchi Paniculati add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate is concentrated into relative density 1.20～1.25(60 ℃) clear paste; Behind refined honey, lanoline, the propylene glycol heating and melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat that temperature adds above-mentioned clear paste and stirs mixing when being down to 45～55 ℃; Add above-mentioned fine powder, stir, mixing, cream core processed, and place sticker, and get final product.
Characteristics of the present invention
1, technical breakthrough, the present invention adopts unique transdermal drag delivery, at many levels, multi-faceted dispenser, the Effective Raise medicament sees through the ability of epidermis, solved that medicine in the past is difficult to see through the epidermis collenchyme and a difficult problem of eradicating rapidly the rheumatalgia arthralgia, guarantee the therapeutic effect of rheumatalgia arthralgia, prevent recurrence.
2, directly impose on the affected part, Transdermal absorption, medicine directly infiltrates focus deep skin tissue.Avoid the loss of medication amount and to human viscera organ's poisoning.
3, demonstrate fully tcm characteristic and advantage, product is through a large amount of clinical verifications, and it is to epiderm skin tissue, subcutaneous tissue not damaged, and nonirritant has no side effect.Be clinical experience and the gains in depth of comprehension therapy of creating out simple and direct practicability and effectiveness external treatment of summing up for many years, solved a difficult problem how to eliminate the cause of disease, solved the difficult problem of deep medicament infiltration.
Adopt external treatment treatment rheumatic arthritis 46 examples, obtain satisfied effect, be reported as follows.
1. physical data
Male's 20 examples in this law treatment, women's 26 examples; 10～80 years old age, average 43.5 years old; The course of disease 3 months～8 years, average 4.7 years.
2. Therapeutic Method
External, the cleaning affected part.Open the separate paper of patch during use, be affixed on painful area or effect point-application, each one pastes, and every subsides were used 1～3 day, or followed the doctor's advice.7 days is 1 course for the treatment of.Be used in conjunction the 2-3 course for the treatment of.
3. therapeutic effect
Criterion of therapeutical effect: recovery from illness: limbs joint pain, swelling, the symptoms such as joint stuffiness all disappeared in 3 courses for the treatment of, and are overcast and rainy and tired rear without sense of discomfort; Produce effects: symptom disappears substantially, overcast and rainy and tired after sense of discomfort slightly; Effectively: transference cure still has mild pain and sour reinfection, overcast and rainy increasing the weight of, limitation of movement more than 80%; Invalid: symptom is without obvious improvement after 3 courses for the treatment of.
Through this law treatment recovery from illness 26 examples, produce effects 18 examples, effective 1 example, invalid 1 example, total effective rate 97.6%.Following up a case by regular visits to relapse rate after half a year is 4.3%, and recurrent cases adopts this law treatment still effective.
Model case
Lee, woman, 60 years old, first visit on November 10 in 2009.The right gonalgia of patient is met cold increasing the weight of, joint stuffiness 6 years, and nearly 1 month sx↑, right knee joint swelling is obvious, and multi-treatment is invalid.Be diagnosed as rheumatic arthritis.Impose this law external treatment, local swelling disappears substantially after 2 days.The walking of can leaving the bed after 6 days, activities freely after 3 weeks.Follow up a case by regular visits to and had no recurrence in 1 year.
4. conclusion
This law dehumidifies with dispersing wind and cold, removing obstruction in the collateral to relieve pain and making laws, and act on the part, and through sick institute, the fraud of decreasing stomach without impairment of YANG, easy to use again, can yet be regarded as and treat the desirable effective ways of rheumatic arthritis.Pain also had good analgesic effect around the joint that this patch causes proliferative arthritis, soft tissue injury reached.Differentiation of symptoms and signs for classification of syndrome belongs to wind, cold, arthralgia chiefly caused by damp pathogen type person effect is better than wind, wet, pyretic arthralgia type.
Description of drawings
Fig. 1 is the production technological process of plaster.
The specific embodiment
Embodiment 1 presses column weight amount weighting raw materials (unit: g)
Radix Angelicae Pubescentis 100g, Rhizoma Corydalis 80g, Herba Asari 85g, Flos Carthami 35g, Rhizoma Homalomenae 50g, Herba Lycopodii 45g, Daphne giraldii Nitsche 55g, Radix Clematidis 45g, Fructus Liquidambaris 50g, Radix Notoginseng 45g, Rhizoma Chuanxiong 40g, Radix Cynanchi Paniculati 45g, Radix Angelicae Dahuricae 45g, Camphora 25g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
Embodiment 2 presses column weight amount weighting raw materials (unit: g)
Radix Angelicae Pubescentis 105g, Rhizoma Corydalis 85g, Herba Asari 80g, Flos Carthami 40g, Rhizoma Homalomenae 45g, Herba Lycopodii 40g, Daphne giraldii Nitsche 50g, Radix Clematidis 40g, 55 parts of Fructus Liquidambaris, 50 parts of Radix Notoginseng, Rhizoma Chuanxiong 45g, Radix Cynanchi Paniculati 40g, Radix Angelicae Dahuricae 50g, Camphora 30g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
Embodiment 3 presses column weight amount weighting raw materials (unit: g) (modification consumption)
Radix Angelicae Pubescentis 110g, Rhizoma Corydalis 90g, Herba Asari 90g, Flos Carthami 30g, Rhizoma Homalomenae 40g, Herba Lycopodii 50g, Daphne giraldii Nitsche 40g, Radix Clematidis 30g, Fructus Liquidambaris 40g, Radix Notoginseng 55g, Rhizoma Chuanxiong 30g, Radix Cynanchi Paniculati 50g, Radix Angelicae Dahuricae 55g, Camphora 35g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
The preparation method of above embodiment is as follows:
Chinese crude drug respectively distinguish the flavor of in will writing out a prescription according to the clean system of regulation under Chinese Pharmacopoeia and this kind item of drug standard, the preparation method of plaster is: Radix Angelicae Pubescentis, Rhizoma Corydalis, Rhizoma Homalomenae, Daphne giraldii Nitsche, Radix Notoginseng, Rhizoma Chuanxiong, Herba Asari, the Radix Angelicae Dahuricae, camphor powder are broken into fine powder (crossing 100 mesh sieves), mixing, for subsequent use; The decocting that Flos Carthami, Herba Lycopodii, Radix Clematidis, Fructus Liquidambaris, Radix Cynanchi Paniculati add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate is concentrated into relative density 1.20～1.25(60 ℃) clear paste; Behind refined honey, lanoline, the propylene glycol heating and melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat that temperature adds above-mentioned clear paste and stirs mixing when being down to 45～55 ℃; Add above-mentioned fine powder, stir, mixing, cream core processed, and place sticker, and get final product.
Using method: external, cleaning affected part.Open the separate paper of patch during use, be affixed on painful area or effect point-application, each one pastes, and every subsides were used 1～3 day, or followed the doctor's advice.
Claims (1)
1. external plaster for the treatment of Fengshi Guanjie pain is characterized in that being made by weight by following bulk drugs:
90～120 parts of Radix Angelicae Pubescentiss, 80～100 parts of Rhizoma Corydalis, 80～100 parts of Herba Asaris, 30～50 parts on Flos Carthami, 40～60 parts of Rhizoma Homalomenaes, 30～50 parts of Herba Lycopodiis, 40～60 parts of Daphne giraldii Nitsche, 30～50 parts of Radix Clematidis, 40～60 parts of Fructus Liquidambaris, 30～60 parts of Radix Notoginseng, 30～50 parts of Rhizoma Chuanxiongs, 30～50 parts of Radix Cynanchi Paniculatis, 40～60 parts of the Radixs Angelicae Dahuricae, 20～40 parts of Camphoras, 10～20 parts of laurocaprams, 150～250 parts of refined honeys, 100～250 parts of lanolines, 70～150 parts of propylene glycol;
The preparation method of above-mentioned plaster is: Radix Angelicae Pubescentis, Rhizoma Corydalis, Rhizoma Homalomenae, Daphne giraldii Nitsche, Radix Notoginseng, Rhizoma Chuanxiong, Herba Asari, the Radix Angelicae Dahuricae, camphor powder is broken into fine powder, crosses 100 mesh sieves, and mixing, for subsequent use; The decocting that Flos Carthami, Herba Lycopodii, Radix Clematidis, Fructus Liquidambaris, Radix Cynanchi Paniculati add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate, relative density is 1.20～1.25 clear paste when being concentrated into 60 ℃; Behind refined honey, lanoline, the propylene glycol heating and melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat that temperature adds above-mentioned clear paste and stirs mixing when being down to 45～55 ℃; Add above-mentioned fine powder, stir, mixing, cream core processed, and place sticker, and get final product.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100459920A CN102579719A (en) | 2012-02-27 | 2012-02-27 | Externally applied plaster for treating rheumatoid arthralgia |
| CN201210045992.0 | 2012-02-27 | ||
| CN201310006163.6A CN103070998B (en) | 2012-02-27 | 2013-01-08 | Externally-applied plaster for curing pain of rheumatic joints |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310006163.6A CN103070998B (en) | 2012-02-27 | 2013-01-08 | Externally-applied plaster for curing pain of rheumatic joints |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103070998A true CN103070998A (en) | 2013-05-01 |
| CN103070998B CN103070998B (en) | 2014-05-14 |
Family
ID=46469321
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100459920A Pending CN102579719A (en) | 2012-02-27 | 2012-02-27 | Externally applied plaster for treating rheumatoid arthralgia |
| CN201310006163.6A Active CN103070998B (en) | 2012-02-27 | 2013-01-08 | Externally-applied plaster for curing pain of rheumatic joints |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100459920A Pending CN102579719A (en) | 2012-02-27 | 2012-02-27 | Externally applied plaster for treating rheumatoid arthralgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN102579719A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361923A (en) * | 2008-09-11 | 2009-02-11 | 周功庚 | Traditional Chinese medicine for treating rheumatism |
| AU2009101063A4 (en) * | 2009-10-21 | 2010-02-25 | G & W Aust Pty Ltd | Herbal compositions and uses for male support, male well-being, sexual performance and normal sexual libido |
| CN101721498A (en) * | 2008-10-24 | 2010-06-09 | 常涛 | Medicine for treating rheumatism |
-
2012
- 2012-02-27 CN CN2012100459920A patent/CN102579719A/en active Pending
-
2013
- 2013-01-08 CN CN201310006163.6A patent/CN103070998B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361923A (en) * | 2008-09-11 | 2009-02-11 | 周功庚 | Traditional Chinese medicine for treating rheumatism |
| CN101721498A (en) * | 2008-10-24 | 2010-06-09 | 常涛 | Medicine for treating rheumatism |
| AU2009101063A4 (en) * | 2009-10-21 | 2010-02-25 | G & W Aust Pty Ltd | Herbal compositions and uses for male support, male well-being, sexual performance and normal sexual libido |
Non-Patent Citations (3)
| Title |
|---|
| SHANG-GAO LIAO.ET AL: "New Phenolic Components from Daphne giraldii", 《HELVETICA CHIMICA ACTA》 * |
| 劳惠兰等: "综合治疗类风湿关节炎60例疗效观察", 《现代中西医结合杂志》 * |
| 陈乐天等: "祖师麻抗类风湿性关节炎有效部位的药效学研究", 《现代中药研究与实践》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103070998B (en) | 2014-05-14 |
| CN102579719A (en) | 2012-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
| CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
| CN105535495A (en) | Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method | |
| CN102240351B (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
| CN104825956A (en) | Medicine for preventing and treating stroke and recovering muscles, bones and joints | |
| CN102178797B (en) | Preparation method of traditional Chinese medicine for treating acute pancreatitis caused by engorgement | |
| CN103142897B (en) | Medicine used after esophageal achalasia operation | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
| CN103142898B (en) | Preparation method of medicine used after esophageal achalasia operation | |
| CN103623335B (en) | A kind of Chinese medicine preparation for the treatment of rhinitis | |
| CN103301309B (en) | Traditional Chinese herbal medicine for treating laryngocarcinoma and esophagus cancer | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN103191339B (en) | Method for preparing drug for treating pediatric esophageal achalasia | |
| CN102631633B (en) | Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis | |
| CN105287798A (en) | Lipid-lowering and slimming recovery pill | |
| CN104906349A (en) | Traditional Chinese medicine oral liquid for treating gastric ulcer and preparation method thereof | |
| CN104083633A (en) | Medicine for treating bowel dysfunction and preparation method thereof | |
| CN103948765A (en) | Traditional Chinese medicine composition for treating thyroiditis by assaulting fortified positions and dredging collaterals and preparation method of composition | |
| CN103191338B (en) | Pharmaceutical composition for treating pediatric esophageal achalasia | |
| CN103191335B (en) | Pharmaceutical composition for treating esophageal achalasia | |
| CN102698012A (en) | Externally applied traditional Chinese medicine for treating oral lichen planus | |
| CN102961662A (en) | Medicine for treating gastric ulcer and preparation method thereof | |
| CN103191336B (en) | Method for preparing drug for treating esophageal achalasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210425 Address after: 237000 Anhui city of Lu'an Province Economic and Technological Development Zone Heng Yuan Patentee after: ANHUI SHILONG BIOMEDICAL TECHNOLOGY Co.,Ltd. Address before: 710075 hi tech three road wealth center, hi tech Zone, Shaanxi, Xi'an Patentee before: Wang Shilong |